|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,280.00 JPY | +0.47% |
|
-3.06% | -6.55% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Beauty Care Products | ||||||||||
Cosmetics | 38.32B | 47.03B | 48.18B | 49.76B | 50.52B | |||||
Total Assets | 53.4B | 50.6B | 50.05B | 50.65B | 50.42B | |||||
CAPEX | -417M | -397M | -503M | -828M | -2.21B | |||||
D&A | 947M | 945M | 731M | 568M | 511M | |||||
Operating Income | 9.6B | 10.81B | 11.87B | 12.23B | 12.29B | |||||
Pharmaceutical Products | ||||||||||
Pharmaceuticals & Health Food | 11.12B | 11.41B | 11.98B | 11.44B | 11.54B | |||||
Total Assets | 17.42B | 16.75B | 16.88B | 15.63B | 14.33B | |||||
CAPEX | -114M | -206M | -268M | -141M | -340M | |||||
D&A | 489M | 471M | 401M | 298M | 283M | |||||
Operating Income | 1.44B | 1.16B | 1.18B | 1.23B | 980M | |||||
Durable Goods Distribution | ||||||||||
Other | 2.09B | 2.97B | 2.67B | 2.89B | 2.93B | |||||
Total Assets | 2.47B | 2.72B | 2.58B | 2.7B | 2.49B | |||||
CAPEX | -7M | -1M | -202M | -66M | -5M | |||||
D&A | 90M | 65M | 118M | 141M | 70M | |||||
Operating Income | 156M | 381M | 260M | 330M | 301M | |||||
Unallocated Adjustment | -260M | -265M | -276M | -275M | -266M | |||||
Total Assets | 7.15B | 6.71B | 7.74B | 7.48B | 9.25B | |||||
CAPEX | - | - | - | - | - | |||||
D&A | -32M | -30M | -30M | - | - | |||||
Operating Income | -2.64B | -2.24B | -2.29B | -2.36B | -2.5B |
Geographical Revenue Distribution History
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Japan | 51.27B | 61.14B | 62.55B | 63.82B | 64.72B | |||||
Total Assets | 80.45B | 76.78B | 77.25B | 76.47B | 76.49B | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | 2.51B | 3.51B | 3.48B | 3.53B | 3.69B | |||||
D&A | 1.49B | 1.45B | 1.22B | 1.01B | 898M | |||||
CAPEX | -433M | -613M | -736M | -626M | -2.27B | |||||
Gross Profit | 33.03B | 42.09B | 42.56B | 43.16B | 43.28B | |||||
Net Income | 6.38B | 7.59B | 7.67B | 7.97B | 8.03B | |||||
EBT | 8.97B | 11.16B | 11.3B | 11.62B | 11.88B | |||||
Operating Income | 8.56B | 10.12B | 11.02B | 11.42B | 11.08B |
- Stock Market
- Equities
- 4928 Stock
- Financials Noevir Holdings Co., Ltd.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















